Metastatic Colorectal Cancer New Study Concepts with Panitumumab

被引：0
|
作者：
Arnheim, Katharina
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：705 / 705
页数：1
相关论文
共 50 条
  • [31] Panitumumab: A fully human monoclonal antibody with activity in metastatic colorectal cancer
    Saadeh, Claire E.
    Lee, H. Stephen
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (04) : 606 - 613
  • [32] Pharmacokinetics of Irinotecan With and Without Panitumumab Coadministration in Patients With Metastatic Colorectal Cancer
    Yang, Bing-Bing
    Wu, Chi-Yuan
    Chen, Eric
    Infante, Jeffrey R.
    Chen, Alin
    Gao, Bing
    Smith, Brian
    Litten, Jason
    Kennecke, Hagen
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (03): : 205 - 212
  • [33] Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer
    Olivier Bouché
    Meher Ben Abdelghani
    Jean-Luc Labourey
    Simon Triby
    René-Jean Bensadoun
    Thomas Jouary
    Gaétan Des Guetz
    World Journal of Gastroenterology, 2019, (29) : 4007 - 4018
  • [34] The efficacy of panitumumab in refractory metastatic colorectal cancer: A meta-analysis
    Duan, Kun-Feng
    Wang, Hua
    JOURNAL OF BUON, 2019, 24 (04): : 1457 - 1463
  • [35] EFFICACY OF CETUXIMAB/PANITUMUMAB AFTER PREVIOUS BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
    Gherman, Alexandra
    Cainap, Calin
    Vesa, Stefan-Cristian
    Havasi, Andrei Dan
    Trifon, Alexandra
    Cainap, Simona Sorana
    Crisan, Ovidiu
    Irimie, Alexandru
    FARMACIA, 2020, 68 (04) : 656 - 664
  • [36] Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer
    Strickler, John H.
    Rushing, Christel N.
    Uronis, Hope E.
    Morse, Michael A.
    Niedzwiecki, Donna
    Blobe, Gerard C.
    Moyer, Ashley N.
    Bolch, Emily
    Webb, Renee
    Haley, Sherri
    Hatch, Ace J.
    Altomare, Ivy P.
    Sherrill, Gary B.
    Chang, David Z.
    Wells, James L.
    Hsu, S. David
    Jia, Jingquan
    Zafar, S. Yousuf
    Nixon, Andrew B.
    Hurwitz, Herbert I.
    ONCOLOGIST, 2021, 26 (06): : 465 - +
  • [37] Panitumumab in Patients With Metastatic Colorectal Cancer (mCRC) - Single Center Experience
    Lopez Lopez, C.
    Novas Vidal, P.
    Gutierrez Sanz, L.
    Garicano Goldaraz, F.
    Hernandez Garcia, I.
    Vega Gil, N.
    Blanco Mesonero, Y.
    Salcedo Lambera, M.
    Rivera Herrero, F.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S429 - S429
  • [38] Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer care
    Martinelli, Erika
    Morgillo, Floriana
    Troiani, Teresa
    Tortora, Giampaolo
    Ciardiello, Fortunato
    CORE EVIDENCE, 2007, 2 (02) : 81 - 88
  • [39] Panitumumab improves progression-free survival in metastatic colorectal cancer
    不详
    ONCOLOGY-NEW YORK, 2005, 19 (14): : 1800 - 1801
  • [40] A BUDGET IMPACT MODEL FOR THE INTRODUCTION OF PANITUMUMAB, A NEW THERAPY FOR THE MANAGEMENT OF METASTATIC COLORECTAL CANCER (MCRC) IN GREECE
    Papagiannopoulou, V
    Christodoulopoulou, A.
    Bracco, A.
    Yfantopoulos, I
    VALUE IN HEALTH, 2008, 11 (06) : A493 - A493
12345